Pharmacogenomics in allogeneic hematopoietic stem cell transplantation: Implications on supportive therapies and conditioning regimens

被引：0
|
作者：
Morris, Sarah A. [1 ,2 ]
Nguyen, D. Grace [1 ,2 ]
Patel, Jai N. [1 ,2 ]
机构：
[1] Atrium Hlth, Dept Canc Pharmacol & Pharmacogen, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
[2] Atrium Hlth, Levine Canc Inst, 1021 Morehead Med Dr, Charlotte, NC 28204 USA
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2023年 / 36卷 / 02期
关键词：
Pharmacogenomics; Pharmacogenetics; Supportive care; Bone marrow transplant; Hematopoietic stem cell transplantation; Allogeneic transplantation; VERSUS-HOST-DISEASE; CONSORTIUM CPIC GUIDELINES; DRUG-METABOLIZING-ENZYMES; CYCLOPHOSPHAMIDE PHARMACOKINETICS; CYP2C19; POLYMORPHISMS; GENE POLYMORPHISMS; PEDIATRIC-PATIENTS; VORICONAZOLE; ASSOCIATION; TACROLIMUS;
D O I：
10.1016/j.beha.2023.101470
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Allogeneic hematopoietic stem cell transplantation mortality has declined over the years, though prevention and management of treatment-related toxicities and post-transplant complications remains challenging. Applications of pharmacogenomic testing can potentially mitigate adverse drug outcomes due to interindividual variability in drug metabolism and response. This review summarizes clinical pharmacogenomic applications relevant to hematopoietic stem cell transplantation, including antifungals, immunosuppressants, and supportive care management, as well as emerging pharmacogenomic evidence with conditioning regimens.
引用
收藏
页数：11
相关论文
共 50 条
  • [31] Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning
    Servais, Sophie
    Baron, Frederic
    Beguin, Yves
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 44 (02) : 205 - 210
  • [32] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
    Frère, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 (04) : 411 - 418
  • [33] Microbiome Changes After Conditioning Regimen for allogeneic hematopoietic stem cell transplantation
    Chiusolo, P.
    Metafuni, E.
    Sterbini, F. Paroni
    Giammarco, S.
    Masucci, L.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S378 - S379
  • [34] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
    P Frère
    F Baron
    C Bonnet
    K Hafraoui
    M Pereira
    E Willems
    G Fillet
    Y Beguin
    Bone Marrow Transplantation, 2006, 37 : 411 - 418
  • [35] Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation
    Andersen, J
    Heilmann, C
    Jacobsen, N
    Nielsen, C
    Bendtzen, K
    Müller, K
    BONE MARROW TRANSPLANTATION, 2006, 37 (07) : 635 - 640
  • [36] Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine
    Carella, AM
    HEMATOLOGY JOURNAL, 2004, 5 : S68 - S75
  • [37] Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation
    J Andersen
    C Heilmann
    N Jacobsen
    C Nielsen
    K Bendtzen
    K Müller
    Bone Marrow Transplantation, 2006, 37 : 635 - 640
  • [38] Allogeneic hematopoietic stem cell transplantation
    Faul, C.
    ONKOLOGIE, 2012, 35 : 112 - 112
  • [39] Allogeneic hematopoietic stem cell transplantation
    Kai, S
    Hara, T
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (03) : 285 - 291
  • [40] DECLINE IN BONE MINERAL DENSITY IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: IMPACT OF MYELOABLATIVE VERSUS REDUCED INTENSITY CONDITIONING REGIMENS
    McCullough, K. B.
    Burzynski, J. A.
    Hogan, W. J.
    Litzow, M. R.
    Wolf, R. C.
    Wermers, R. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S353 - S354
12345